A Form 4 filed on August 18, 2026 by Freshpet, Inc. Chief Executive Officer and Director William B. Cyr reported the exercise of stock options and sale of common stock on August 14, 2026, across directly and indirectly held accounts.

Key Highlights

  • Options exercised (direct): Cyr exercised 62,369 options at $10.23 per share, acquiring common stock directly, leaving 305,917 options beneficially owned directly after the transaction.
  • Shares sold (direct): 41,023 shares were sold at a weighted average price of $72.91, with individual transactions ranging from $72.902 to $72.912 per share.
  • Indirect holdings affected: Options and shares were also exercised and sold across three indirect accounts: shares held by spouse, the Irrevocable Spousal Trust for Linda W. Cyr, and the Linda W. Cyr 2020 Irrevocable Trust for Descendants.
  • Post-transaction direct ownership: Following all reported transactions, Cyr directly beneficially owned 245,805 shares of common stock.
  • Rule 10b5-1 plan: According to the filing, the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
  • Options fully vested: The filing states the exercised options were issued under Freshpet's 2014 Omnibus Incentive Plan and were "fully vested as of December 31, 2020."

Cyr's August 14 Option Exercises and Stock Sales Across Multiple Accounts

According to the filing, William B. Cyr, Chief Executive Officer and Director of Freshpet, Inc. (NASDAQ:FRPT), executed a series of transactions on August 14, 2026. In his directly held account, Cyr exercised 62,369 options to purchase common stock at an exercise price of $10.23 per share (transaction code M), and subsequently sold 41,023 shares (transaction code S) at a weighted average price of $72.91. The filing notes those shares were sold in multiple transactions at prices ranging from $72.902 to $72.912 per share. After these transactions, Cyr's direct beneficial ownership of common stock stood at 245,805 shares, with 305,917 options remaining directly held.

The filing also reports transactions across three indirect accounts. In the account held by his spouse, 4,620 options were exercised at $10.23 and 651 shares were sold at $72.82, leaving 29,534 shares and 22,660 options indirectly owned via the spouse. In the Irrevocable Spousal Trust for Linda W. Cyr, 9,030 options were exercised at $10.23 and 1,271 shares were sold at $72.82, resulting in 68,391 shares and 44,290 options remaining. In the Linda W. Cyr 2020 Irrevocable Trust for Descendants, 7,981 options were exercised at $10.23 and 1,124 shares were sold at $72.82, leaving 62,978 shares and 39,133 options in that account.

The filing states all sales were made pursuant to a Rule 10b5-1 trading plan the reporting person adopted on November 5, 2025. The exercised options were issued under the issuer's 2014 Omnibus Incentive Plan and, per the filing, were fully vested as of December 31, 2020. The form was signed by Andrew Lampert as attorney-in-fact for the reporting person and filed on August 18, 2026.

What Was Disclosed

Freshpet CEO William B. Cyr reported the exercise of stock options and sale of common stock on August 14, 2026, across direct and three indirect beneficial ownership accounts, pursuant to a pre-established Rule 10b5-1 trading plan adopted November 5, 2025.